- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
8 result(s) found for: Intraoral.
Displaying page 1 of 1.
EudraCT Number: 2010-019953-16 | Sponsor Protocol Number: 1009435 | Start Date*: 2010-08-31 |
Sponsor Name:Royal Devon & Exeter Foundation Trust | ||
Full Title: A Preliminary Randomised Controlled Trial using Standard Therapy Vs Mugard | ||
Medical condition: Chemotherapy and radiotherapy induced oral mucositis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004975-22 | Sponsor Protocol Number: ORN-2014-16 | Start Date*: 2015-09-03 |
Sponsor Name:Oral and Maxillofacial Surgery Department of Vall d'Hebron Hospital | ||
Full Title: Advances in the management of mandibular osteoradionecrosis: Pentoxyfilline and Tocopherol as medical treatment. | ||
Medical condition: Assess whether there is a clinically significant reduction in intraoral bone exposure (measured in mm) in the experimental group after the start of treatment with pentoxifylline and tocopherol (PEN... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003790-41 | Sponsor Protocol Number: JAN12006-01 | Start Date*: 2015-05-11 |
Sponsor Name:Spherium Biomed | ||
Full Title: Randomised, double-blinded, placebo and active comparator controlled exploratory clinical trial to assess the efficacy and safety of a triple combination of Ibuprofen, magnesium and ascorbic acid ... | ||
Medical condition: Temporomandibular joint dysfunction syndrome. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003940-21 | Sponsor Protocol Number: 46361 | Start Date*: 2014-03-20 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Systemic antibiotic therapy (amoxicillin plus metronidazole) as an adjunct to surgical treatment of peri-implantitis; a single blind randomized controlled study | ||
Medical condition: peri-implantitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020538-24 | Sponsor Protocol Number: GASAS-1002X | Start Date*: 2011-02-16 |
Sponsor Name:GABA International AG | ||
Full Title: White spot lesion development in post-orthodontic patients following weekly application of a 1.25% fluoride gel compared to placebo over 6 months | ||
Medical condition: To monitor the white spot lesion development and dental status under weekly applied 1.25% fluoride gel compared to placebo in patients after orthodontic treatment with multibracket appliances | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004724-11 | Sponsor Protocol Number: 294568 | Start Date*: 2014-09-22 |
Sponsor Name:Karolinska Institute | ||
Full Title: Surgical treatment of peri-implantitis with and without systemically adjunctive antibiotics A prospective, open, randomized, three armed, parallel, placebo controlled clinical trial | ||
Medical condition: peri-implantitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002996-32 | Sponsor Protocol Number: 12UK/DCsc04 | Start Date*: 2012-11-12 | |||||||||||
Sponsor Name:IBSA Institut Biochimique S.A. | |||||||||||||
Full Title: Preliminary evaluation of the efficacy and local tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, administered locally prior to surgery for the prevention of post-operative pain a... | |||||||||||||
Medical condition: post-surgical pain after lower third molar removal. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2020-005534-15 | Sponsor Protocol Number: PRO-GLY-002/E2013 | Start Date*: 2021-04-01 |
Sponsor Name:Proveca Pharma LTD | ||
Full Title: Double-blind, placebo-controlled, randomized clinical trial comparing the efficacy and safety of Sialanar plus oral rehabilitation against placebo plus oral rehabilitation for children and adolesce... | ||
Medical condition: Severe sialorrhoea and neurodisabilties in children | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
